<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02500862</url>
  </required_header>
  <id_info>
    <org_study_id>4C-2015-08</org_study_id>
    <nct_id>NCT02500862</nct_id>
  </id_info>
  <brief_title>Characterization of Potential Biomarkers of Eye Disease and Vision</brief_title>
  <acronym>EYE-MARKER</acronym>
  <official_title>Characterization of Potential Biomarkers of Eye Disease and Vision Loss.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Association for Innovation and Biomedical Research on Light and Image</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Association for Innovation and Biomedical Research on Light and Image</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Characterize potential biomarkers of sight-threatening eye diseases based on the information&#xD;
      acquired in clinical practice at CEC, AIBILI&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a registry study. Only patients followed under the clinical practice at AIBILI&#xD;
      Clinical Trial Centre, and with a signed informed consent form will be included.&#xD;
&#xD;
      Based on the clinical information collected under the clinical practice, and based on&#xD;
      patients' characteristics, scientific questions will be raised and data will be collected and&#xD;
      analysed accordingly.&#xD;
&#xD;
      Any procedure performed under clinical practice that may allow for the characterization of&#xD;
      the disease and/or for the identification of potential biomarkers will be collected and&#xD;
      analysed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Actual">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI.</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Eye Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient followed under the normal clinical practice at AIBILI Clinical Trial Centre,&#xD;
        and with a AIBILI signed informed consent form for data collection, Imp. 11-7-2&#xD;
        &quot;Consentimento Informado para tratamento de dados&quot;.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any patient followed under the normal clinical practice at AIBILI Clinical Trial&#xD;
             Centre, and with a AIBILI signed informed consent form for data collection, Imp.&#xD;
             11-7-2 &quot;Consentimento Informado para tratamento de dados&quot;.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria L Ribeiro, MsC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Association for Innovation and Biomedical Research on Light and Image</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CEC</name>
      <address>
        <city>Coimbra</city>
        <zip>3000-548</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>July 10, 2015</study_first_submitted>
  <study_first_submitted_qc>July 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 17, 2015</study_first_posted>
  <last_update_submitted>June 21, 2021</last_update_submitted>
  <last_update_submitted_qc>June 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Eye</keyword>
  <keyword>Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

